{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "19639171",
  "DateCompleted": {
    "Year": "2009",
    "Month": "10",
    "Day": "01"
  },
  "DateRevised": {
    "Year": "2019",
    "Month": "06",
    "Day": "06"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [],
    "Journal": {
      "ISSN": "1019-6439",
      "JournalIssue": {
        "Volume": "35",
        "Issue": "3",
        "PubDate": {
          "Year": "2009",
          "Month": "Sep"
        }
      },
      "Title": "International journal of oncology",
      "ISOAbbreviation": "Int J Oncol"
    },
    "ArticleTitle": "Diagnostic importance of overexpression of Bmi-1 mRNA in early breast cancers.",
    "Pagination": {
      "StartPage": "511",
      "EndPage": "515",
      "MedlinePgn": "511-5"
    },
    "Abstract": {
      "AbstractText": [
        "Target molecules for a highly sensitive and specific diagnosis of breast cancer in its early clinical stages have not yet been identified. Here, we show the first evidence for diagnostic performance of the molecule B cell-specific Moloney murine leukemia virus integration site 1 (Bmi-1) in breast cancer patients. Only 5 out of 46 non-cancerous samples were positive for Bmi-1 mRNA expression resulting in a sensitivity and specificity of 72.0 and 91.3%, respectively. The mRNA expression was estimated using the cut-off value obtained from the receiver operating characteristic curve analysis. Further, Bmi-1 mRNA expression was found to be elevated in 97.8% (45/46) of cancerous tissues in comparison to the expression in paired cancerous tissues and non-cancerous tissues obtained from identical patients. Bmi-1 mRNA was found to be highly expressed even in the early clinical stages of breast cancer. Our results suggest that Bmi-1 mRNA might be a new tool to support the diagnosis of breast cancers, irrespective of the clinical stage."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Clinical Laboratory Medicine, Sapporo Medical University School of Medicine, Chuo-Ku, Sapporo, Japan."
          }
        ],
        "LastName": "Saeki",
        "ForeName": "Masachika",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Kobayashi",
        "ForeName": "Daisuke",
        "Initials": "D"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Tsuji",
        "ForeName": "Naoki",
        "Initials": "N"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Kuribayashi",
        "ForeName": "Kageaki",
        "Initials": "K"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [],
        "LastName": "Watanabe",
        "ForeName": "Naoki",
        "Initials": "N"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Greece",
    "MedlineTA": "Int J Oncol",
    "NlmUniqueID": "9306042",
    "ISSNLinking": "1019-6439"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "BMI1 protein, human"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Biomarkers, Tumor"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Nuclear Proteins"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Proto-Oncogene Proteins"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "RNA, Messenger"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Repressor Proteins"
    },
    {
      "RegistryNumber": "EC 2.3.2.27",
      "NameOfSubstance": "Polycomb Repressive Complex 1"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "analysis"
      ],
      "DescriptorName": "Biomarkers, Tumor"
    },
    {
      "QualifierName": [
        "genetics",
        "pathology"
      ],
      "DescriptorName": "Breast Neoplasms"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Gene Expression"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Immunohistochemistry"
    },
    {
      "QualifierName": [
        "biosynthesis",
        "genetics"
      ],
      "DescriptorName": "Nuclear Proteins"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Polycomb Repressive Complex 1"
    },
    {
      "QualifierName": [
        "biosynthesis",
        "genetics"
      ],
      "DescriptorName": "Proto-Oncogene Proteins"
    },
    {
      "QualifierName": [
        "analysis"
      ],
      "DescriptorName": "RNA, Messenger"
    },
    {
      "QualifierName": [],
      "DescriptorName": "ROC Curve"
    },
    {
      "QualifierName": [
        "biosynthesis",
        "genetics"
      ],
      "DescriptorName": "Repressor Proteins"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Reverse Transcriptase Polymerase Chain Reaction"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Sensitivity and Specificity"
    }
  ]
}